Regulatory Eli Lilly wins FDA approval for weight loss pill, tees up Novo rivalry Pharmaceutical TechnologyLilly's product, known under the brand name Foundayo, has a clear route to early blockbuster status.RegulatoryMetabolic & GLP-1Read full story pharminent April 2, 2026 (Last updated: April 2, 2026) Pharmaceutical Technology Lilly’s product, known under the brand name Foundayo, has a clear route to early blockbuster status. RegulatoryMetabolic & GLP-1Read full story Post navigation Previous: Building What’s Next: Join Industry Leaders to Shape Access and Affordability Trends Ahead of Asembia AXS26Next: ACC 2026: Meta-analysis supports CagriSema as superior first-line therapy in obesity Related Stories Regulatory Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval pharminent September 14, 2026 Regulatory Psychedelic therapies ride wave of public favor into FDA hearing pharminent September 14, 2026 Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026